Remove 2018 Remove Testimonials Remove Trials
article thumbnail

Let's Quit Sugar With Audiobook – Let's Quit Sugar

The Pharma Data

Testimonials are not necessarily representative of all of those who will use our products. Some of our testimonials are provided by customers who have received promotional offers in exchange for their participation. The testimonials displayed are given verbatim except for correction of grammatical or typing errors. De Araujo IE.

Disease 52
article thumbnail

Unblock My Hormones And Start Burning Fat TODAY With HB5

The Pharma Data

In a major double-blind clinical trial published in the American College of Endocrinology…. Which has been proven in numerous clinical trials to: Rhodiola is a flowering plant that grows in the remote regions of the Arctic… And in a major randomized, double-blind, and placebo-controlled study published in the Journal Planta Medica….

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Another RICOdiculous Decision

Drug & Device Law

Second, as for superiority, PATDC82 II admitted that a class trial would face “enormous logistical hurdles,” but nonetheless found a nationwide class action “superior.” Thus, “[o]ne supposed ‘nightmare’ trial is preferable to many hundreds of shorter ones.” 30, 2018); In re Skelaxin (Metaxalone) Antitrust Litigation , 299 F.R.D.

article thumbnail

50-State Survey of State Court Decisions Supporting Expert-Related Judicial Gatekeeping

Drug & Device Law

We think that they can, and for a state (like Pennsylvania and a number of others) that still follows the “ Frye ” standard looking to the “general acceptance” of expert testimony as the touchstone to admissibility, a Rule 702 state-law equivalent might look something like this: Rule 702. E.g. , Walsh v. BASF Corp. , 3d 446, 461 (Pa.

article thumbnail

Ruling On Motion To Dismiss In A Pennsylvania (Prescription) Device Case Takes Us Back

Drug & Device Law

After more than a month away at trial, we probably should not have picked a case that hit so close to home, so to speak. The court did not mention that the manufacturer was sold in 2018.) Instead, it looked to Pennsylvania’s ultimate requirement of proof of expert testimony to prove a prescription drug (!!!) Wyeth , 85 A.3d

article thumbnail

New Fed. R. Evid. 702 – Use This Stuff To Update Your Briefs

Drug & Device Law

Testimony by expert witnesses. First, the Committee found it necessary to “emphasize” both the court’s role and the burden of proof. “[E]xpert testimony may not be admitted unless the proponent demonstrates to the court that it is more likely than not that the proffered testimony meets the admissibility requirements set forth in the rule.”

article thumbnail

Pro Se Plaintiff Tries and Fails To Plead Claims For Failure To Withdraw And Failure To Warn

Drug & Device Law

In two of these cases, our client won summary judgment at the trial court level and an appellate court ended up creating a new cause of action to accommodate the plaintiff’s theory (and lack of helpful testimony from the prescribing physician). There was a similar endorsement in 2018.